AfroCentric: H1 22A Insights

H1 22A results snapshot: Revenue +10% y/y (+3% h/h); EBITDA +5% y/y (-12% h/h), which meant the EBITDA margin moderated by 64bps y/y to 12.5%. Normalized HEPS (N.HEPS) and DPS were stable y/y at ZAr 26.51 and ZAr 17 (4% dividend yield), respectively. Shares in issue...

AfroCentric Investment Corporation: Initiation

Execution of a clearly defined strategy has seen AfroCentric Investment Corporation (ACT) deliver a robust performance in the last ten years: Revenue and adjusted EBITDA have increased by a CAGR of 20% and 15%, respectively. This has translated into diluted HEPS and...